Why is Incyte Corp. ?
- The company has declared positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 1,979.7 MM
- ROCE(HY) Highest at 30.67%
- INTEREST COVERAGE RATIO(Q) Highest at 124,892.27
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 44.05%, its profits have risen by 4556%
How much should you buy?
- Overall Portfolio exposure to Incyte Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Incyte Corp. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 1,979.7 MM
Highest at 30.67%
Highest at 124,892.27
Fallen by -0.48% (YoY
Highest at USD 8,551.56 MM
Lowest at -70.89 %
Highest at 5.91 times
Highest at USD 1,674.04 MM
Highest at USD 726.87 MM
Highest at 43.42 %
Highest at USD 744.21 MM
Highest at USD 579.91 MM
Highest at USD 2.81
Lowest at 1.85 times
Here's what is working for Incyte Corp.
Operating Cash Flows (USD MM)
Operating Profit to Interest
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Sales (USD MM)
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Cash and Cash Equivalents
Debt-Equity Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Incyte Corp.
Inventory Turnover Ratio






